Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Clasificación en acciones #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Precio por acción
$0.14942078
Última sincronización: 2025-05-15
Capitalización bursátil
$3.86M
Cambio (1 día)
0.10%
Cambio (1 año)
0.00%
País
DE
Comercio Medigene AG (MDG1)

Categoría

Ingresos de Medigene AG (MDG1)
Ingresos en Jun 2024 TTM: $7.99M
Según los últimos informes financieros de Medigene AG, los ingresos actuales de la empresa (TTM) son $7.99M. En 2022, la empresa obtuvo unos ingresos de $33.52M un aumento con respecto a los ingresos del año 2021, que fueron de $11.90M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Medigene AG desde 2004 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $7.99M 19.85%
2023 $6.67M -80.10%
2022 $33.52M 181.71%
2021 $11.90M 22.09%
2020 $9.75M -17.36%
2019 $11.79M 35.46%
2018 $8.71M -5.48%
2017 $9.21M 113.45%
2016 $4.32M 28.15%
2015 $3.37M -77.88%
2014 $15.22M 46.65%
2013 $10.38M 34.07%
2012 $7.74M 160.02%
2011 $2.98M 0.59%
2010 $2.96M -94.55%
2009 $54.28M 16.25%
2008 $46.70M 44.83%
2007 $32.24M -19.79%
2006 $40.20M 73.97%
2005 $23.11M 36.31%
2004 $16.95M 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$12.62B 157,814.80%
US
$6.02B 75,219.06%
NL
- -
CH
- -
KR
$10.11B 126,373.78%
BE